ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

26,183Medicare Part D Prescriptions Filled, Including Refills

Rank: 17 out of 2588

$1.33M Total Retail Price of All Prescriptions

Rank: 39 out of 2588

611 Patients Receiving at Least One Drug in Part D
80%Patients 65 Years and Older
54% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Illinois
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 611 patients filled at least one prescription for a schedule two drug, compared to an average of 1%.

Schedule Three
Controlled Substances

29% of this provider’s 611 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

1% of this provider’s 21,023 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

43 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Illinois
HYDROCODONE-ACETAMINOPHEN 1,066 635 S3 1 7
SIMVASTATIN 872 768 2 1
LISINOPRIL 793 631 3 3
FUROSEMIDE 790 683 4 5
OMEPRAZOLE 744 596 5 6
LEVOTHYROXINE SODIUM 732 669 6 2
METOPROLOL SUCCINATE 607 566 7 12
AMLODIPINE BESYLATE 570 494 8 4
METFORMIN HCL 538 447 9 8
POTASSIUM CHLORIDE 516 432 10 15
LISINOPRIL-HYDROCHLOROTHIAZIDE 439 336 11 35
HYDROCHLOROTHIAZIDE 400 358 12 13
PRAVASTATIN SODIUM 322 277 13 16
WARFARIN SODIUM 305 280 14 10
DONEPEZIL HCL 304 304 15 22
CLOPIDOGREL 301 265 16 30
METOPROLOL TARTRATE 301 277 16 9
ALENDRONATE SODIUM 293 266 18 21
PANTOPRAZOLE SODIUM 288 259 19 28
ROPINIROLE HCL 274 235 20 113
CITALOPRAM HBR 272 216 21 27
RANITIDINE HCL 261 122 22 37
POLYETHYLENE GLYCOL 3350 253 245 23 55
ATORVASTATIN CALCIUM 244 207 24 11
NAMENDA 240 240 25 32
TAMSULOSIN HCL 228 203 26 23
ESCITALOPRAM OXALATE 227 188 27 68
SPIRONOLACTONE 225 204 28 58
CRESTOR 224 150 29 25
SERTRALINE HCL 224 179 29 26
PLAVIX 218 195 31 43
GABAPENTIN 212 136 32 18
MELOXICAM 207 177 33 51
SYNTHROID 207 185 33 88
KLOR-CON M20 206 188 35 52
PREDNISONE 195 174 36 42
TRAMADOL HCL 195 118 36 19
AMLODIPINE BESYLATE-BENAZEPRIL 185 152 38 76
ALLOPURINOL 181 154 39 33
FLUOXETINE HCL 168 132 40 92
ATENOLOL 167 159 41 14
LEVOXYL 157 116 42 245
PROAIR HFA 142 85 43 50
ADVAIR DISKUS 142 109 43 48
CYCLOBENZAPRINE HCL 141 59 R 45 87
LEVOFLOXACIN 139 106 46 77
TORSEMIDE 136 104 47 133
SINGULAIR 136 93 47 94
TRICOR 134 106 49 122
ZOLPIDEM TARTRATE 134 82 49 24
LOVASTATIN 133 133 51 34
FENOFIBRATE 130 114 52 64
FAMOTIDINE 129 91 53 36
OXYBUTYNIN CHLORIDE ER 126 97 54 85
NEXIUM 126 87 54 41
DIOVAN HCT 120 98 56 72
DICYCLOMINE HCL 119 89 57 215
FLUTICASONE PROPIONATE 118 101 58 40
NORTRIPTYLINE HCL 117 83 59 237
METFORMIN HCL ER 117 81 59 67
AZITHROMYCIN 116 85 61 45
CELEBREX 115 102 62 99
LANTUS SOLOSTAR 114 89 63 93
CARVEDILOL 112 87 64 20
CYMBALTA 111 39 65 70
PAROXETINE HCL 110 78 66 71
NAPROXEN 104 28 67 95
FELODIPINE ER 104 87 67 108
GLIMEPIRIDE 104 74 67 39
RISPERIDONE 103 100 70 57
AMITRIPTYLINE HCL 99 83 R 71 91
SPIRIVA 94 65 72 56
CIPROFLOXACIN HCL 93 80 73 82
MONTELUKAST SODIUM 93 69 73 153
METHYLPREDNISOLONE 92 52 75 144
KLOR-CON M10 92 86 75 139
NABUMETONE 91 78 77 147
CARBIDOPA-LEVODOPA 87 73 78 83
BACLOFEN 86 42 79 142
LANTUS 86 71 79 47
DIOVAN 86 81 79 29
TRIAMCINOLONE ACETONIDE 84 67 82 106
GEMFIBROZIL 84 65 82 123
GLIPIZIDE ER 83 83 84 73
TRAZODONE HCL 81 37 85 61
PHENYTOIN SODIUM EXTENDED 80 50 86 109
OXYCONTIN 77 45 S2 87 273
BUSPIRONE HCL 74 40 88 173
ISOSORBIDE MONONITRATE ER 73 68 89 49
LOSARTAN POTASSIUM 73 67 89 17
BUPROPION XL 72 47 91 256
ACTOS 72 49 91 105
BYSTOLIC 70 70 93 110
TRILIPIX 69 40 94 185
FENTANYL 68 53 S2 95 78
DOXYCYCLINE HYCLATE 68 51 95 151
DIGOXIN 68 61 95 38
DILTIAZEM 24HR CD 67 63 98 98
SULFAMETHOXAZOLE-TRIMETHOPRIM 67 53 98 127
MECLIZINE HCL 67 64 98 120
CLONIDINE HCL 67 63 98 54
CARBAMAZEPINE 65 40 102 146
TIZANIDINE HCL 65 22 102 225
LEXAPRO 64 52 104 182
LOSARTAN-HYDROCHLOROTHIAZIDE 61 59 105 66
NYSTATIN 58 42 106 196
VENLAFAXINE HCL ER 57 40 107 125
ENALAPRIL MALEATE 56 56 108 31
HYDRALAZINE HCL 55 55 109 53
LOVAZA 55 41 109 119
ZETIA 54 37 111 69
IPRATROPIUM-ALBUTEROL 53 53 112 104
PRADAXA 53 44 112 207
NIFEDICAL XL 53 53 112 179
GLIPIZIDE 52 38 115 44
MUPIROCIN 51 51 116 235
VENTOLIN HFA 50 25 117 101
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 12, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.